tiprankstipranks
Advertisement
Advertisement

VCYT Stock Latest News

VCYT Upcoming Earnings Report: What to Expect?
Pre-EarningsVCYT Upcoming Earnings Report: What to Expect?
2d ago
VCYT
Canadian AI Microcap Cut Hospital Drug Alerts by 94%. Now It’s Entering the U.S. (TSXV: SEGN)
PremiumTipRanks Newswire
Canadian AI Microcap Cut Hospital Drug Alerts by 94%. Now It’s Entering the U.S. (TSXV: SEGN)
14d ago
GH
JTAI
Veracyte initiated with an Overweight at Piper Sandler
PremiumThe Fly
Veracyte initiated with an Overweight at Piper Sandler
15d ago
VCYT
Veracyte price target raised to $60 from $42 at Canaccord
PremiumThe Fly
Veracyte price target raised to $60 from $42 at Canaccord
16d ago
VCYT
Veracyte price target raised to $47 from $37 at Morgan Stanley
PremiumThe Fly
Veracyte price target raised to $47 from $37 at Morgan Stanley
21d ago
VCYT
Veracyte price target raised to $65 from $45 at Guggenheim
PremiumThe FlyVeracyte price target raised to $65 from $45 at Guggenheim
1M ago
VCYT
TSLA, AMZN, PLTR, RKLB, and More: Cathie Wood Takes Profits Across Tech in All-Sell Session — 6/16/26
Premium
Market News
TSLA, AMZN, PLTR, RKLB, and More: Cathie Wood Takes Profits Across Tech in All-Sell Session — 6/16/26
1M ago
TXG
AMZN
Veracyte shareholders endorse board, pay and incentive plans
Premium
Company Announcements
Veracyte shareholders endorse board, pay and incentive plans
2M ago
8K
VCYT
Cathie Wood Sells $7.5M in Robinhood Stock. Here Are Her Latest Trades, 6/11/26
PremiumMarket News
Cathie Wood Sells $7.5M in Robinhood Stock. Here Are Her Latest Trades, 6/11/26
2M ago
KDK
ARKQ
Veracyte assumed with an Outperform at Wolfe Research
PremiumThe Fly
Veracyte assumed with an Outperform at Wolfe Research
2M ago
VCYT
Veracyte announces U.S. commercial launch of Prosigna ROR test
PremiumThe Fly
Veracyte announces U.S. commercial launch of Prosigna ROR test
2M ago
VCYT
Veracyte announces results from Enzamet trial presented at 2026 ASCO meeting
PremiumThe Fly
Veracyte announces results from Enzamet trial presented at 2026 ASCO meeting
2M ago
VCYT
Veracyte Oncology Portfolio Progress Supports Buy Rating and Unchanged $48 Price Target
PremiumRatingsVeracyte Oncology Portfolio Progress Supports Buy Rating and Unchanged $48 Price Target
2M ago
VCYT
Veracyte’s TrueMRD Monitoring Test receives coverage from CMS
Premium
The Fly
Veracyte’s TrueMRD Monitoring Test receives coverage from CMS
3M ago
VCYT
Veracyte price target raised to $42 from $40 at Canaccord
Premium
The Fly
Veracyte price target raised to $42 from $40 at Canaccord
3M ago
VCYT
Veracyte price target raised to $52 from $48 at UBS
PremiumThe Fly
Veracyte price target raised to $52 from $48 at UBS
3M ago
VCYT
Veracyte Earns Buy Rating on Consistent Outperformance, Raised Guidance and Attractive Optionality From Upcoming Pipeline Launches
PremiumRatings
Veracyte Earns Buy Rating on Consistent Outperformance, Raised Guidance and Attractive Optionality From Upcoming Pipeline Launches
3M ago
VCYT
Veracyte Inc Earnings Call Signals Profitable Growth
PremiumCompany Announcements
Veracyte Inc Earnings Call Signals Profitable Growth
3M ago
VCYT
Veracyte Inc (VCYT) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Veracyte Inc (VCYT) Q1 Earnings Cheat Sheet
3M ago
VCYT
Veracyte announces new data at AUA 2026 on Decipher portfolio
PremiumThe FlyVeracyte announces new data at AUA 2026 on Decipher portfolio
3M ago
VCYT
Veracyte price target lowered to $40 from $43 at Canaccord
Premium
The Fly
Veracyte price target lowered to $40 from $43 at Canaccord
3M ago
VCYT
Veracyte initiated with a Buy at Jefferies
Premium
The Fly
Veracyte initiated with a Buy at Jefferies
4M ago
VCYT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >